medigraphic.com
Archivos de Medicina (Manizales)

2021, Number 2

<< Back Next >>

Arch Med 2021; 21 (2)

Mayaro virus, an alphavirus forgotten in Colombia: possible effect on public health

Lozada-Martínez I, Bolaño-Romero M, Arroyo-Salgado B

Language: Spanish
References: 43
Page: 523-531
PDF size: 690.57 Kb.


ABSTRACT

About Mayaro virus, there is currently little knowledge of its transmission and patho-genesis. It is known to inhabit different areas of the Western Hemisphere and is trans-mitted by the Aedes aegypti and albopictus (Diptera: Culicidae). Numerous authors have focused their research given coexistence in scenarios where the circulations of all these viruses can somehow overlap and generate mixed infections. This agent has been gaining prominence at the public health level, due to the possibility of causing high risk of outbreaks with serious clinical manifestations similar to that of Zika viruses, Chikungunya virus and Dengue, in several countries, such as Trinidad, Brazil, Mexico, Venezuela, Honduras, Salvador, Costa Rica, Panama, Peru, Argentina, Suriname, Guyana, Venezuela, Ecuador and Bolivia. Colombia is looking forward to a conco-mitant onset in the near future along with ZIKV and CHIKV. Taking into account the above, a thorough search was carried out of the existing literature, on Mayaro virus, its molecular structure, transmission cycle, clinical symptomatology, diagnostic methods, risk factors, control and prevention, as well as treatment, to learn a broader picture of the problem that lurks. All this, through search engines like PubMed, Science Direct, Clinical Key and Ebsco.


REFERENCES

  1. Acosta-Ampudia Y, Monsalve DM, Rodríguez Y, Pacheco Y, Anaya JM, Ramírez-Santana C. Mayaro: an emer-ging viral threat? Emerg Microbes Infect.2018; 7(1):1-11. DOI: 10.1038/s41426-018-0163-5

  2. Cardona-Ospina JA, Villamil-Gómez WE, Jimenez-Canizales CE, Castañeda-Hernandez DM, Rodríguez-Morales AJ. Estimating the burden of disease and the economic cost attributable to chikungunya, Colombia, 2014.Trans R Soc Trop Med Hyg. 2015; 109(12):793-802. DOI: 10.1093/trstmh/trv094

  3. Pacheco O, Beltrán M, Nelson CA, Valencia D, Tolosa N, Farr SL, et al. Zika Virus Disease in Colombia - Pre-liminary Report.N Engl J Med. 2020; 383(6):1-10. DOI: 10.1056/NEJMoa1604037

  4. Llagonne-Barets M, Icard V, Leparct-Goffart I, Prat C, Perpoint T, André P, et al. A case of Mayaro virus infec-tion imported from French Guiana.J Clin Virol. 2016;77:66–68. DOI: 10.1016/j.jcv.2016.02.013

  5. Receveur MC, Grandadam M, Pistone T, Malvy D. Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010.Euro Surveill. 2010; 15(18):1-4. DOI: 10.3201/eid1804.111717

  6. Theilacker C, Held J, Allering L, Emmerich P, Schmidt-Chanasit J, Kern WV, et al. Prolonged polyarthralgia in a German traveller with Mayaro virus infection without inflammatory correlates. BMC Infect Dis. 2013; 13:1-4. DOI: 10.1186/1471-2334-13-369

  7. Instituto Nacional de Salud. Comportamiento de las arbovirosis a periodo epidemiológico IX de 2018. Co-lombia: 2018. Disponible en: https://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2018%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%2039.pdf

  8. Arredondo AE, Guerrero G, de Quezada F, Santana O. Presencia y diseminación del Dengue, Chikungunya y otras arbovirosis en las Américas. Rev Med Electrón. 2019; 41(2):423-434. ID: biblio-1004278

  9. Rodríguez AJ, Anaya JM. Impact of emerging arthritogenic arboviruses in Colombia and Latin America.Rev Colomb Reumatol. 2016; 23(3):145-147. DOI: 10.1016/j.rcreu.2016.08.001

  10. Esposito DL, Lopes- da Fonseca BA. Will Mayaro virus be responsible for the next outbreak of an arthropod-borne virus in Brazil? Braz J Infect Dis. 2017; 21(5):540-544. DOI: 10.1016/j.bjid.2017.06.002

  11. Lednicky J, Beau VM, Elbadry M, Loeb J, Telisma T, Chavannes S, et al. Mayaro Virus in Child with Acute Febrile Illness, Haiti, 2015. Emerg Infect Dis. 2016; 22(11):2000-2002. DOI: 10.3201/eid2211.161015

  12. Anderson CR, Downs WG, Wattley GH, Ahin NW, Reese AA. Mayaro virus: a new human disease agent. Am J Trop Med Hyg. 1957; 6(6):1012-1016. DOI: 10.4269/ajtmh.1957.6.1012

  13. Auguste AJ, Liria J, Forrester NL, Giambalvo D, Moncada M, Long KC, et al. Evolutionary and Ecological Characterization of Mayaro Virus Strains Isolated during an Outbreak, Venezuela, 2010. Emerg Infect Dis.2015; 21(10):1742-1750. DOI: 10.3201/eid2110.141660

  14. Lavergne A, de Thoisy B, Lacoste V, Pascalis H, Pouliquen JF, Mercier V, et al. Mayaro virus: complete nucleoti-de sequence and phylogenetic relationships with other alphaviruses.Virus Res. 2006 May; 117(2):283-90. DOI: 10.1016/j.virusres.2005.11.006

  15. Mavian C, Rife BD, Dollar JJ, Cella E, Ciccozzi M, Prosperi MC, et al. Emergence of recombinant Mayaro virus strains from the Amazon basin. Sci Rep. 2017; 7(1):1-11. DOI: 10.1038/s41598-017-07152-5

  16. Wiggins K, Eastmond B, Alto BW. Transmission potential of Mayaro virus in Florida Aedes aegypti and Aedes albopictus mosquitoes.Med Vet Entomol. 2018; 32(4):436-442. DOI: 10.1111/mve.12322

  17. Muñoz M, Navarro JC. Mayaro: un arbovirus re-emergente en Venezuela y Latinoamerica.Biomédica. 2012; 32(2):286-302. DOI: 10.7705/biomedica.v32i2.647

  18. Rey J, Lounibos P. Ecología de Aedes aegypti y Aedes albopictus. Biomédica. 2015;35:177-85. DOI: 10.7705/biomedica.v35i2.2514

  19. 19. Ganjian N, Riviere-Cinnamond A. Mayaro virus in Latin America and the Caribbean. Rev Panam Salud Publica. 2020; 44:1-11. DOI: 10.26633/RPSP.2020.14

  20. Blohm G, Elbadry MA, Mavian C, Stephenson C, Loeb J, White S, et al. Mayaro as a Caribbean traveler: Evi-dence for multiple introductions and transmission of the virus into Haiti. Int J Infect Dis. 2019; 87:151-153. DOI: 10.1016/j.ijid.2019.07.031

  21. Diagne CT, Bengue M, Choumet V, Hamel R, Pompon J, Missé D. Mayaro Virus Pathogenesis and Transmis-sion Mechanisms. Pathogens.2020; 9(9):1-23. DOI: 10.3390/pathogens9090738

  22. Bogoch I, Brady OJ, Kraemer M, German M, Creatore M, Brent S, et al. Potential for Zika virus introduction and transmission in resource-limited countries in Africa and the Asia-Pacific region: A modelling study.Lancet Infect. Dis. 2016; 16:1237-1245. DOI:10.1016/S1473-3099(16)30270-5

  23. Sun J, Wu D. Mayaro virus, a regional or global threat? Travel Med Infect Dis. 2019; 32:1-1. DOI: 10.1016/j.tmaid.2019.07.018

  24. Mackay IM, Arden KE. Mayaro virus: a forest virus primed for a trip to the city. Microbes Infect. 2016; 18(12):724-734. DOI: 10.1016/j.micinf.2016.10.007

  25. Napoleão-Pego P, Pinto-Gomes L, Provance DW, De-Simone SG. Mayaro virus disease.J Hum Virol Retrovirol. 2014; 1(3):1-11. DOI: 10.15406/jhvrv.2014.01.00018

  26. Junt T, Heraud J, Lelarge J, Labeau B, Talarmin A. Determination of natural versus laboratory human infec-tion.Epidemiol Infect. 1999;123:511-13. DOI:10.1017/s0950268899003180

  27. Santiago FW, Halsey ES, Siles C, Vilcarromero S, Guevara C, Silvas JA, et al. Long-Term arthralgia after Ma-yaro virus infection correlates with sustained pro-inflammatory cytokine response.PLoS Negl Trop Dis.2015; 9(10):1-14. DOI:10.1371/journal.pntd.0004104

  28. Paniz AE, Rodriguez AJ, Blohm G, Marquez M, Villamil WE. ChikDenMaZika Syndrome: the challenge of diagnosing arboviral infections in the midst of concurrent epidemics. Ann Clin Microbiol Antimicrob. 2016; 15(1):42. DOI: 10.1186/s12941-016-0157-x

  29. Wang E, Paessler S, Aguilar PV, Carrara AS, Ni H, Greene IP, et al. Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections. J Clin Microbiol. 2006; 44(11):4000-4008. DOI: 10.1128/JCM.00175-06

  30. Halsey ES, Siles C, Guevara C, Vilcarromero S, Jhonston EJ, Ramal C, et al. Mayaro virus infection, Amazon Basin region, Peru, 2010–2013. Emerg Infect Dis. 2013; 19(11):1839–1842. DOI: 10.3201/eid1911.130777

  31. Bronzoni RV, Moreli ML, Cruz AC, Figueiredo LT. Multiplex nested PCR for Brazilian Alphavirus diagnosis.Trans R Soc Trop Med Hyg. 2004; 98(8):456-461. DOI: 10.1016/j.trstmh.2003.09.002

  32. Naveca FG, Nascimento VAD, Souza VC, Nunes BTD, Rodrigues DSG, Vasconcelos PF. Multiplexed reverse transcription real-time polymerase chain reaction for simultaneous detection of Mayaro, Oropouche, and Oropouche-like viruses.Mem Inst Oswaldo Cruz. 2017; 112(7):510-513. DOI: 10.1590/0074-02760160062

  33. Waggoner JJ, Rojas A, Mohamed-Hadley A, Arévalo-de Guillén Y, Pinsky BA. Real-time RT-PCR for Mayaro virus detection in plasma and urine.J Clin Virol. 2018; 98:1-4. DOI: 10.1016/j.jcv.2017.11.006

  34. Powers A, Aguilar P, Chandler L, Brault A, Meakins T, Watts D, et al. Genetic relationships among Mayaro and Una viruses suggest distinct patterns of transmission.Am J Trop Med Hyg. 2006;75:461-9. DOI: 10.4269/ajtmh.2006.75.461

  35. Aguilar MA, Del Valle J, Silva W, Gil T, Levy S, Bazán J, et al. An emerging public health threat: Mayaro virus increases its distribution in Peru.Int J Infect Dis. 2020; 92:253-258. DOI: 10.1016/j.ijid.2020.01.024

  36. Sakkas H BP, Franks A, Papadopoulou C. Oropouche fever: A review.Viruses. 2018; 10(4):1-16.

  37. Weise WJ, Hermance ME, Forrester N, Adams AP, Langsjoen R, Gorchakov R, et al. A novel live-attenuated vaccine candidate for mayaro fever.PLoS Negl Trop Dis. 2014; 8(8):1-9. DOI: 10.1371/journal.pntd.0002969

  38. Leparc-Goffart I, Nougairede A, Cassadou S, Prat C, de Lamballerie X. Chikungunya in the Americas.Lancet.2014; 383(9916):514-514. DOI: 10.1016/S0140-6736(14)60185-9

  39. Choi H, Kudchodkar SB, Reuschel EL, Asija K, Borole P, Ho M, et al. Protective immunity by an engineered DNA vaccine for Mayaro virus. PLoS Negl Trop Dis. 2019; 13(2):1-21. DOI: 10.1371/journal.pntd.0007042

  40. Hoque H, Islam R, Ghosh S, Rahaman MM, Jewel NA, Miah MA. Implementation of in silico methods to pre-dict common epitopes for vaccine development against Chikungunya and Mayaro viruses. Heliyon. 2021; 7(3):1-11. DOI: 10.1016/j.heliyon.2021.e06396

  41. Amorim R, de Meneses MDF, Borges JC, da Silva Pinheiro LC, Caldas LA, Aires L, et al. Thieno[2,3-b]pyridine derivatives: a new class of antiviral drugs against Mayaro virus.Arch Virol. 2017; 162(6):1577-1587. DOI: 10.1007/s00705-017-3261-0

  42. Ferreira PG, Ferraz AC, Figueiredo JE, Lima CF, Rodrigues VG, Taranto AG, et al. Detection of the antiviral activity of epicatechin isolated from Salacia crassifolia (Celastraceae) against Mayaro virus based on protein C homology modelling and virtual screening.Arch Virol. 2018; 163(6):1567-1576. DOI: 10.1007/s00705-018-3774-1

  43. Valencia-Marín BS, Duarte-Gandica I, Aguirre-Obando OA. The Mayaro virus and its potential epidemiological consequences in Colombia: an exploratory biomathematics analysis.Parasit Vectors. 2020; 13(1):1-16. DOI: 10.1186/s13071-020-04354-1




2020     |     www.medigraphic.com